ResearcherPeking UniversityActive in the last 2 years
Yinying Lu
Matched on ORCID iD 0000-0002-7737-2334; OpenAlex author ID A5041358858. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 13
2021: 1 paper · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 3
- Single-cell analysis uncovers liver susceptibility to pancreatic cancer metastasis via myeloid cell characterization. Last author DOI 10.1007/s12672-024-01566-0↗
- Single-cell RNA-seq integration unveils liver vulnerability to tumor metastases: insights from myeloid cell characterization in pancreatic cancer liver metasta… Last author DOI 10.21203/rs.3.rs-3668911/v1↗
- Chinese expert consensus of image-guided irreversible electroporation for pancreatic cancer. Co-author DOI 10.4103/jcrt.jcrt_1663_20↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Aizier Ainiwaer · 2 shared papers, 2023–2024 · strength 0.47
- Paper Single-cell analysis uncovers liver susceptibility to pancreatic cancer metastasis via myeloid cell characterization. DOI 10.1007/s12672-024-01566-0↗
- Paper Single-cell RNA-seq integration unveils liver vulnerability to tumor metastases: insights from myeloid cell characteriz… DOI 10.21203/rs.3.rs-3668911/v1↗
- Yingtian Wei · 1 shared paper, 2021 · strength 0.08
- Chengli Li · 1 shared paper, 2021 · strength 0.08
- Tianan Jiang · 1 shared paper, 2021 · strength 0.08
- Liwei Wang · 1 shared paper, 2021 · strength 0.08
- Ming Kuang · 1 shared paper, 2021 · strength 0.08
- Junhui Sun · 1 shared paper, 2021 · strength 0.08
- Haipeng Yu · 1 shared paper, 2021 · strength 0.08
- Kai‐Wen Huang · 1 shared paper, 2021 · strength 0.08
- Yingxun Zhang · 1 shared paper, 2021 · strength 0.08
- Maoquan Li · 1 shared paper, 2021 · strength 0.08
- Lizhi Niu · 1 shared paper, 2021 · strength 0.08
- Xiaoyi Ding · 1 shared paper, 2021 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.